BamSEC and AlphaSense Join Forces
Learn More

Endo Pharmaceuticals Solutions Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages First Supplemental Indenture
12/34/56
EX-10.1
from 8-K 14 pages Memorandum of Understanding 1
12/34/56
EX-10.1
from 8-K 4 pages First Amendment to Amended and Restated License, Commercialization and Supply Agreement
12/34/56
EX-10.4
from SC TO-C 19 pages Form of Octreotide Contingent Cash Consideration Agreement by and Between Endo Pharmaceuticals Holdings Inc. and American Stock Transfer & Trust Company as Paying Agent Dated as of [ ], 2009
12/34/56
EX-10.3
from SC TO-C 24 pages Form of Nebido Contingent Cash Consideration Agreement by and Between Endo Pharmaceuticals Holdings Inc. and American Stock Transfer & Trust Company as Paying Agent Dated as of [ ], 2009
12/34/56
EX-10.2
from SC TO-C 12 pages Form of Stockholder Tender Agreement
12/34/56
EX-10.1
from SC TO-C 81 pages Agreement and Plan of Merger by and Among Endo Pharmaceuticals Holdings Inc. Btb Purchaser Inc. and Indevus Pharmaceuticals, Inc. Dated as of January 5, 2009
12/34/56
EX-10.219
from 10-K 91 pages B a C K G R O U N D
12/34/56
EX-10.218
from 10-K 24 pages Pledge and Security Agreement Made by Each Undersigned Equityholder to U.S. Bank National Association, as Trustee Dated as of August 26, 2008
12/34/56
EX-10.217
from 10-K 115 pages Indenture Dated as of August 26, 2008 by and Between Ledgemont Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes Described Herein, and U.S. Bank National Association, as Initial Trustee of the Notes Described Herein
12/34/56
EX-10.216
from 10-K 46 pages Note Purchase Agreement Dated August 26, 2008 Among Ledgemont Royalty Sub LLC, Indevus Pharmaceuticals, Inc. and the Purchaser Named Herein $105,000,000 Ledgemont Pharmasm Secured 16% Notes Due 2024
12/34/56
EX-10.215
from 10-K 50 pages Purchase and Sale Agreement Dated as of August 26, 2008 Between Indevus Pharmaceuticals, Inc. and Ledgemont Royalty Sub LLC
12/34/56
EX-10.208
from 10-K 82 pages License, Supply and Distribution Agreement by and Between Indevus Pharmaceuticals, Inc. and Orion Corporation
12/34/56
EX-10.1
from 8-K 3 pages Amendment to Executive Retirement Agreement
12/34/56
EX-10.2
from 10-Q 1 page On March 11, 2008, Deferred Stock Units (Dsus) Were Granted to Each Non-Employee Member of the Board of Directors of Indevus Pharmaceuticals, Inc. (The “Company”) Pursuant to the Company’s 2004 Equity Incentive Plan. Each Director Received 10,000 Dsus and Each Dsu Represents the Right to Receive One Share of the Company’s Common Stock. the Dsus Vest Over Three Years and the Vested Portion of the Award Is Distributable After the Earlier of the Director’s Retirement From the Board or Five Years From the Date of Grant
12/34/56
EX-10.3
from 8-K 5 pages Retention Agreement
12/34/56
EX-10.2
from 8-K 5 pages Retention Agreement
12/34/56
EX-10.1
from 8-K 5 pages Retention Agreement
12/34/56
EX-10.1
from 8-K 9 pages Executive Retirement Agreement
12/34/56
EX-10.180
from 10-K 37 pages Collaboration and Development Agreement
12/34/56